SRL Diagnostics, the largest Pathology chain in the country, is all set to transform its lab at Fortis Memorial Research Institute with Roche Diagnostics’ integrated analyser series. With this installation, SRL Diagnostics is well on the path to establishing an Integrated Core Lab. This integration will bring enormous benefits to SRL and its patients.
The inauguration of the new breakthrough platform was done by Mr Anand K, CEO, SRL Diagnostics along with Dr Ritu Mittal Garg, Zonal Director Fortis Memorial Research Institute and Narendra Varde, Managing Director, Roche Diagnostics India and Neighboring markets.
Speaking on the occasion, Anand K, CEO, SRL Diagnostics said, “Just as every patient requires personalised care, every laboratory is unique. Our lab at FMRI is one of our premium labs and hence striking a balance between high standards and efficient operations require us to adopt tailor-made solutions. Being one of the largest diagnostics chain in the country, we are always looking to adopt the latest technology solutions and platforms that offer our customers a better experience. Roche has developed a platform concept that delivers individualized solutions based on common architecture for various workloads and testing requirements thereby allowing us to achieve faster result turnaround that leads to better patient care and management.”
Laboratories of the future will encompass integrated systems where lab technicians will no longer need to work in different labs for different disciplines. Instead, their multidisciplinary connectivity will allow a single centralized, automation system to include a single user interface that can run the entire system.
“Diagnostic tools are vital in improving patient care by enabling clinicians to make medical decisions accurately. Labs today want to offer the best but need integrated systems that can offer more. Therefore, demand for increased lab productivity and efficiency per invested space and budget continues to rise. High performing labs need an efficient mix of a broad test menu and fast result turnaround time. The cobas analyzer series consolidates 230+ tests including innovative tests on maternal screening, Alzheimer’s disease, cardiac risks etc. on one system, where most of these samples utilize just a single tube of blood sample. It can also achieve 99% per cent uptime, or 18 minutes or less TAT on 93 per cent of parameters ”, said Narendra Varde, Managing Director, Roche Diagnostics India & Neighboring Markets.”